Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dec-USA is the United States subsidiary of Dec Group, a Swiss provider of powder handling, containment, micronization, aseptic filling, and integrated process equipment used across pharmaceutical, biotech, radiopharma, chemical, and related industries. Rather than developing therapeutic drug candidates, the company supplies engineered equipment and manufacturing solutions that support safe handling of powders, high-potency compounds, and sterile products. Its U.S. operations include a manufacturing hub in Mauston, Wisconsin and a micronization facility in Brick, New Jersey that offers R&D, proof-of-concept, scale-up, and contract micronization services. Dec-USA's offerings are geared toward process development and commercial manufacturing workflows, including containment systems, particle-size reduction, and end-to-end process integration for regulated production environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dec-USA.